Feed aggregator

Analyst Report: Viavi Solutions Inc

Top Stories - Fri, 01/30/2026 - 07:18

Analyst Report: GE Vernova Inc.

Top Stories - Fri, 01/30/2026 - 07:18

Analyst Report: International Business Machine

Top Stories - Fri, 01/30/2026 - 07:18

Analyst Report: Trane Technologies plc

Top Stories - Fri, 01/30/2026 - 07:18

Best high-yield savings interest rates today, January 30, 2026 (up to 4% APY return)

Top Stories - Fri, 01/30/2026 - 06:00

Mortgage and refinance interest rates today, January 30, 2026: Lingering near one-year lows

Top Stories - Fri, 01/30/2026 - 06:00

Best CD rates today, January 30, 2026 (up to 4% APY return)

Top Stories - Fri, 01/30/2026 - 06:00

Best money market account rates today, January 30, 2026 (up to 4.1% APY return)

Top Stories - Fri, 01/30/2026 - 06:00

HELOC and home equity loan rates today, January 30, 2026: As the Fed pauses, so do home equity rates

Top Stories - Fri, 01/30/2026 - 06:00

Octopus Energy Enters China With PCG Power Green Trading Joint Venture

Top Stories - Fri, 01/30/2026 - 04:16

Forget Tech Stocks: The Energy Stock That's Fueling the Data Center Explosion

Top Stories - Fri, 01/30/2026 - 04:05

Bank of Thailand plans to tighten regulations on online gold trading as its price soars

Top Stories - Fri, 01/30/2026 - 04:04

Bitcoin price sub $80,000? Investors flee amid tech selloff, government shutdown fears

Top Stories - Fri, 01/30/2026 - 03:54

Heard on the Street Thursday Recap: Gold Swings

Top Stories - Fri, 01/30/2026 - 03:51

Arthur Hayes Says $300B Liquidity Drain Is Driving Bitcoin Lower

Top Stories - Fri, 01/30/2026 - 03:41

Binance Converts SAFU Fund to Bitcoin After Oct. 10 Backlash—Will it Restore Trust or Add Risk?

Top Stories - Fri, 01/30/2026 - 03:37

HSBC UK, Sage launch digital tax tool ahead of MTD change

Top Stories - Fri, 01/30/2026 - 03:35

1 Thing to Watch in Peloton's Earnings on Feb. 5

Top Stories - Fri, 01/30/2026 - 03:35

Is Advanced Micro Devices a Good AI Stock to Buy Right Now?

Top Stories - Fri, 01/30/2026 - 03:34

How Big Pharma is navigating a $300 billion patent cliff

Top Stories - Fri, 01/30/2026 - 03:00
Syndicate content
 
Worldstockexchange® Information Center